 | Up a level |
Carevic, M; Öz, H; Fuchs, K; Laval, J; Schroth, C; Frey, N; Hector, A; Bilich, T; Haug, M; Schmidt, A; Autenrieth, S E; Bucher, K; Beer-Hammer, S; Gaggar, A; Kneilling, M; Benarafa, Charaf; Gao, J L; Murphy, P M; Schwarz, S; Moepps, B; ... (2016). CXCR1 Regulates Pulmonary Anti-Pseudomonas Host Defense. Journal of innate immunity, 8(4), pp. 362-373. Karger 10.1159/000444125
Latzin, P; Hartl, D; Regamey, N; Frey, U; Schoeni, M H; Casaulta, C (2008). Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis. European respiratory journal, 31(1), pp. 36-42. Sheffield, UK: European Respiratory Society 10.1183/09031936.00078107
Griese, M; Latzin, P; Kappler, M; Weckerle, K; Heinzlmaier, T; Bernhardt, T; Hartl, D (2007). alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients. European respiratory journal, 29(2), pp. 240-50. Sheffield, UK: European Respiratory Society 10.1183/09031936.00047306
Latzin, P; Beck-Ripp, J; Hartl, D; Bartenstein, A; Noss, J; Griese, Matthias (2007). 8-Isoprostane in nasally exhaled breath condensate in different pediatric lung diseases. European journal of medical research, 12(1), pp. 21-5. München: I. Holzapfel
